tiprankstipranks
Trending News
More News >

New Portfolio Jan 2023 - New Portfolio

Assen

New Portfolio Jan 2023
Individual Investor
Ranked #519,795 out of 833,364 TipRanks' Investors
Success Rate
43%
49 out of 113
profitable transactions
Average Return
3.20%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 2.17%
6-Month Return▲ 12.32%
12-Month Return▲ 7.58%
YTD Return▲ 7.00%
Total Return▲ 9.78%

Best Trade

Opened at
Closed at-
Gain▲ 294.18%

Bio

LT focused portfolio with primary investment in EU based companies

Performance

12.88%0-12.88%
▲ 11.63%
▲ 6.28%
▲ 2.80%
May 2025
▲ 9.25%
▲ 5.14%
▼ 1.52%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 2.64%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 3.98%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 0.42%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 3.59%
Oct 2025
▼ 3.57%
▲ 0.19%
▲ 0.43%
Nov 2025
▼ 0.06%
▲ 0.51%
▲ 0.51%
Dec 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 11.63%▲ 6.28%▲ 2.80%
▲ 9.25%▲ 5.14%▼ 1.52%
▲ 7.60%▲ 2.30%▲ 2.64%
▲ 2.76%▲ 2.05%▲ 3.98%
▲ 12.88%▲ 3.56%▲ 0.42%
▲ 10.96%▲ 2.38%▲ 3.59%
▼ 3.57%▲ 0.19%▲ 0.43%
▼ 0.06%▲ 0.51%▲ 0.51%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Sanofi
0%
▼ 5.81%
4
Sell
Aug 17, 2025
Kering SA
0%
▼ 16.51%
6
Sell
Aug 17, 2025
Novo Nordisk
17.84%
▼ 42.24%
8
Buy
Aug 17, 2025
The Estée Lauder Companies
0%
▼ 1.09%
7
Sell
Aug 17, 2025
Tesla
10.98%
▲ 98.26%
3
Buy
Aug 17, 2025
Nvidia
8.25%
▲ 119.35%
5
Buy
Aug 17, 2025
EssilorLuxottica SA
5.74%
▲ 21.82%
3
Buy
Aug 17, 2025
LVMH Moet Hennessy Louis Vuitton
13.76%
▲ 8.16%
4
Buy
Aug 17, 2025
Barry Callebaut AG
0%
▼ 17.83%
2
Sell
Aug 17, 2025
Eli Lilly & Co
7.95%
▲ 50.63%
1
Open
Aug 17, 2025
Remy Cointreau
0.98%
▼ 60.85%
7
Buy
May 14, 2025
Brown Forman A
0.62%
▼ 37.83%
4
Buy
May 14, 2025
L'Oreal
3.21%
▼ 9.15%
2
Buy
May 14, 2025
TotalEnergies SE
4.9%
▼ 0.08%
2
Buy
May 14, 2025
Air Liquide
▲ 13.40%
4
Close
Sep 27, 2024
Ferrari
0%
▼ 16.95%
2
Sell
Sep 27, 2024
AXA SA
0%
▲ 28.53%
2
Sell
Sep 27, 2024
Alibaba
0%
▲ 77.07%
2
Sell
Sep 27, 2024
Compagnie Financiere Richemont SA
▼ 5.60%
2
Close
Sep 27, 2024
Bristol-Myers Squibb
0%
▲ 34.99%
2
Sell
Sep 27, 2024